drugset / Trial / NCT01023386
A Clinical Pharmacological Study of YM155 After Intravenous Infusion in Patients With Advanced Cancer
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This study investigates the pharmacokinetics of YM155, identifies the metabolic profile of YM155 and evaluates the safety and tolerability of YM155 after a 3-hour infusion in patients with advanced cancer
Timeline
- Start
- 2009-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SEPANTRONIUM | Small molecule | — | Intravenous |